Heart failure & cardiomyopathiesCohort study
Cardiac Resynchronization With or Without Defibrillator in Nonischemic Cardiomyopathy: A Nationwide Cohort Study (DECIDE-CRT)
- multicenter cohort study
- 170 US Veterans Affairs hospitals
- propensity score approach
- inverse probability of treatment weighting
- nationwide observational study
Authors' conclusion
This nationwide observational study from the Veterans Affairs Health system did not demonstrate a clear survival advantage with the addition of a defibrillator among patients with NICM receiving CRT although residual confounding cannot be excluded. Given the uncertainty surrounding the incremental benefit of the defibrillator in this setting, a randomized trial is needed to test the incremental value of CRT-D over CRT-P in NICM.
Study context
- Population
- Patients with nonischemic cardiomyopathy (NICM) receiving primary-prevention CRT pacemaker (CRT-P) or CRT defibrillator (CRT-D) between January 1, 2006, and December 31, 2020met NICM primary-prevention criteria, of 16,609 cardiac resynchronization therapy (CRT) recipients · CRT-D 3,158 · CRT-P 807
- Participants
- 3,965 patients
- Exposure
- CRT defibrillator versus CRT pacemaker
- CRT-Pn = 807
- CRT-Dn = 3,158reference
Main finding
Mortality rate · median follow-up of 5.2 years
Relative risk
0.97
95% CI 0.71–1.13
P = 0.66
By group
As reported in the abstract
Observational data: associations, not effects.
Secondary outcomes
| Outcome | Estimate | P value | |
|---|---|---|---|
| All-cause mortality · inverse probability of treatment weighting-Cox model | adjusted hazard ratio 0.90 (95% CI 0.71–1.13) | P = 0.34 | |
| Heart failure hospitalization · no difference in adjusted hazard | hazard ratio 1.27 (95% CI 0.86–1.87) | ||
| 0.512Ratio (log scale) |
Generator replacement and device-related infections
- the CRT-D group had higher rates of generator replacement and device-related infections
Baseline characteristics
- patients with NICM receiving CRT-P were much older, with more cardiovascular and noncardiovascular comorbidities compared with the CRT-D group
Original publication
Summarised from the published abstract; every number is checked against it